Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Wouter De Brouwer"'
Autor:
Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, Eline Menu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-17 (2022)
Abstract Background Multiple myeloma (MM) remains an incurable cancer despite advances in therapy. Therefore, the search for new targets is still essential to uncover potential treatment strategies. Metabolic changes, induced by the hypoxic bone marr
Externí odkaz:
https://doaj.org/article/e8e263e6af5e473fb6e4e31c1ab28d5d
Autor:
Ann De Becker, Robbe Heestermans, Wouter De Brouwer, Kara Bockstaele, Ken Maes, Ivan Van Riet
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Mesenchymal stromal cells (MSCs) are non-hematopoietic cells that have a broad therapeutic potential. To obtain sufficient cells for clinical application, they must be expanded ex vivo. In the initial expansion protocols described, fetal calf serum (
Externí odkaz:
https://doaj.org/article/33c1b6329ba94b0bb77c7a256b491d2c
Publikováno v:
Vrije Universiteit Brussel
The diagnostic and therapeutic landscape of multiple myeloma has been in constant evolution, resulting in many novel treatment opportunities for patients with MM, though many challenges remain in providing optimal care for patients with MM. In this a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4dfbe0554a04713453dd4355628e34ff
https://biblio.vub.ac.be/vubir/18th-international-myeloma-workshop-2021(4d5ccfc0-daa5-4a02-8bfd-1216054a7775).html
https://biblio.vub.ac.be/vubir/18th-international-myeloma-workshop-2021(4d5ccfc0-daa5-4a02-8bfd-1216054a7775).html
Autor:
Robbe Heestermans, Wouter De Brouwer, Ken Maes, Isabelle Vande Broek, Freya Vaeyens, Catharina Olsen, Ben Caljon, Ann De Becker, Marleen Bakkus, Rik Schots, Ivan Van Riet
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4901
The analysis of bone marrow (BM) samples in multiple myeloma (MM) patients can lead to the underestimation of the genetic heterogeneity within the tumor. Blood-derived liquid biopsies may provide a more comprehensive approach to genetic characterizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d2cb6d1679da72aa0ddaac85600e167
https://doi.org/10.3390/cancers14194901
https://doi.org/10.3390/cancers14194901
Autor:
Marleen Bakkus, Marie-Françoise Dresse, Wouter De Brouwer, Karel Fostier, Emmanuelle Kabongo, Jona Van der Straeten, Rik Schots, Ivan Van Riet
Publikováno v:
The Journal of molecular diagnostics : JMD. 23(5)
Detection of minimal residual disease (MRD) to guide therapy has been a standard practice in treatment of childhood acute lymphoblastic leukemia (ALL) for decades. In multiple myeloma (MM), a clear correlation is found between absence of MRD and long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc8f15f63d0e2439494be29cf9556a47
https://pubmed.ncbi.nlm.nih.gov/33549860
https://pubmed.ncbi.nlm.nih.gov/33549860